{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:12:06Z","timestamp":1790788326491,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A 70-year-old Japanese woman who was treated for interstitial pneumonia (IP) with steroid therapy developed cholecystitis. A serial computed-tomography (CT) imaging showed irregular thickness of the fundus wall of the gallbladder and two rapidly enlarged lymph nodes (LNs): number (no.) 12 and no. 8a. Positron-emission tomography-computed tomography (PET-CT) scan showed an abnormal uptake at the site of the gallbladder tumor and those LNs. We subsequently performed open radical cholecystectomy and LN dissection of the no. 12 and 8a LNs, following complete remission of IP. The histology showed gallbladder adenocarcinoma, with a single focus of neuroendocrine carcinoma (NEC) component of less than 30%; Ki-67 index\u2009&gt;\u200980%, synaptophysin (Syn) (+), chromogranin A (CgA) (+), and clusters of differentiation (CD) 56 (+) (T2bN1M0, Stage IIIB). LN no. 8a was diffusely metastatic with NEC components. LN no. 12c, which was adjacent to the cystic duct, revealed necrosis without apparent tumor cells, but was highly suspicious for tumor necrosis. The final diagnosis was adenocarcinoma of the gallbladder with focal NEC (&lt;\u200930%), which did not meet the criteria for mixed neuroendocrine\u2013non-neuroendocrine neoplasm (MiNEN). Postoperatively, she completed 4\u00a0cycles of adjuvant chemotherapy for NEC (Cisplatin plus Etoposide), and no recurrence was observed after 12\u00a0months.<\/jats:p>","DOI":"10.1007\/s12328-021-01547-8","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T14:02:36Z","timestamp":1636725756000},"page":"185-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Focal neuroendocrine carcinoma mixed with adenocarcinoma of the gallbladder with aggressive lymph node metastasis in a patient who did not meet the mixed neuroendocrine\u2013non-neuroendocrine neoplasm criteria"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0097-4844","authenticated-orcid":false,"given":"Yoshie","family":"Kadota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Funakoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigemichi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Odaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Yagishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiki","family":"Toriumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"key":"1547_CR1","first-page":"8218","volume":"8","author":"C Chen","year":"2015","unstructured":"Chen C, Wang L, Liu X, et al. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma. Int J Clin Exp Pathol. 2015;8:8218\u201326.","journal-title":"Int J Clin Exp Pathol"},{"key":"1547_CR2","first-page":"292","volume-title":"Digestive system tumours","author":"NV Adsay","year":"2019","unstructured":"Adsay NV, La Rosa S. Neuroendocrine neoplasms of the gallbladder and bile ducts. In: WHO Classification of Tumours Editorial Board, editor. Digestive system tumours. Lyon: International Agency for Research on Cancer; 2019. p. 292\u20134."},{"key":"1547_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00428-012-1212-4","volume":"460","author":"K Harada","year":"2012","unstructured":"Harada K, Sato Y, Ikeda H, et al. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs. Virchows Arch. 2012;460:281\u20139.","journal-title":"Virchows Arch"},{"key":"1547_CR4","first-page":"16","volume-title":"WHO classification of tumours editorial board. Digestive system tumours","author":"DS Klimstra","year":"2019","unstructured":"Klimstra DS, Kl\u00f6ppel G, La Rosa S, et al. Classification of neuroendocrine neoplasms of the digestive system. In: WHO classification of tumours editorial board.  Digestive system tumours. Lyon: International Agency for Research on Cancer; 2019. p. 16\u20139."},{"key":"1547_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.dld.2011.07.010","volume":"43","author":"J Kim","year":"2011","unstructured":"Kim J, Lee WJ, Lee SH, et al. Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours. Dig Liver Dis. 2011;43:965\u201370.","journal-title":"Dig Liver Dis"},{"key":"1547_CR6","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.929511","volume":"22","author":"AC Costa","year":"2021","unstructured":"Costa AC, Cavalcanti CLC, Coelho HGB, et al. Rare mixed adenoneuroendocrine carcinoma of the gallbladder: case report and review of literature. Am J Case Rep. 2021;22: e929511.","journal-title":"Am J Case Rep."},{"key":"1547_CR7","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.21873\/invivo.11662","volume":"33","author":"N Machairas","year":"2019","unstructured":"Machairas N, Paspala A, Frountzas M, et al. Mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: a systematic review of outcomes following surgical management. In Vivo. 2019;33:1721\u20136.","journal-title":"Vivo"},{"key":"1547_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1159\/000475527","volume":"105","author":"L de Mestier","year":"2017","unstructured":"de Mestier L, Cros J, Neuzillet C, et al. Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms. Neuroendocrinology. 2017;105:412\u201325.","journal-title":"Neuroendocrinology"},{"key":"1547_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023271","volume":"99","author":"LJ Wen","year":"2020","unstructured":"Wen LJ, Chen JH, Xu HJ, et al. The clinical profiles, management, and prognostic factors of biliary mixed neuroendocrine nonneuroendocrine neoplasms: a systematic review of the literature. Medicine (Baltimore). 2020;99: e23271.","journal-title":"Medicine (Baltimore)"},{"key":"1547_CR10","doi-asserted-by":"publisher","DOI":"10.2174\/1566524020666200925155614","author":"L Mohammadi","year":"2020","unstructured":"Mohammadi L, Mosayyebi B, Imani M, et al. Correlation between dexamethasone and miRNAs in the regulation of apoptosis, drug-resistance, and metastasis of cancer cell. Curr Mol Med. 2020. https:\/\/doi.org\/10.2174\/1566524020666200925155614.","journal-title":"Curr Mol Med"},{"key":"1547_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12957-016-1039-6","volume":"14","author":"H Okada","year":"2016","unstructured":"Okada H, Uchida Y, Matsuzaki N, et al. A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder. World J Surg Oncol. 2016;14:284.","journal-title":"World J Surg Oncol"},{"key":"1547_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12328-019-01053-y","volume":"13","author":"K Kamei","year":"2020","unstructured":"Kamei K, Shindoh J, Kiya Y, et al. Conversion surgery after extensive chemotherapy for stage IV mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: clinical implications from the patterns of response and recurrence. Clin J Gastroenterol. 2020;13:240\u20136.","journal-title":"Clin J Gastroenterol"},{"key":"1547_CR13","unstructured":"Benson AB, D\u2019Angelica MI, Abbott DE, et al. Biliary tract cancers: gallbladder cancer. In: NCCN clinical practice guidelines in oncology. hepatobiliary cancers (Version 5.2021). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hepatobiliary.pdf. Accessed 21 Sept 2021."},{"key":"1547_CR14","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.6004\/jnccn.2019.0059","volume":"17","author":"DS Ettinger","year":"2019","unstructured":"Ettinger DS, Wood DE, Aggarwal C, et al. NCCN guidelines insights: non-small cell lung cancer, version 1.2020. J Natl Compr Canc Netw. 2019;17:1464\u201372.","journal-title":"J Natl Compr Canc Netw"},{"key":"1547_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/jcm9010273","volume":"9","author":"M Frizziero","year":"2020","unstructured":"Frizziero M, Chakrabarty B, Nagy B, et al. Mixed neuroendocrine non-neuroendocrine neoplasms: a systematic review of a controversial and underestimated diagnosis. J Clin Med. 2020;9:273.","journal-title":"J Clin Med"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01547-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-021-01547-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01547-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T06:27:51Z","timestamp":1645252071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-021-01547-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1547"],"URL":"https:\/\/doi.org\/10.1007\/s12328-021-01547-8","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,12]]},"assertion":[{"value":"17 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yoshie Kadota, Shinsuke Funakoshi, Shigemichi Hirose, Eisuke Shiomi, Masanori Odaira, Haruka Yagishita, Yosuke Kobayashi, Fumiki Toriumi, Seiichi Tamai, Takashi Endo, and Hirohisa Harada declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}